EMN is expected to have benefited from cost-cutting initiatives and its innovation-driven growth strategy amid soft demand in certain markets in Q3.
Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
While EMN faces headwinds from weak demand and inventory de-stocking in certain markets, it benefits from cost management, pricing actions and innovation.
EMN benefits from its innovation-driven growth model and cost-cutting, productivity and price hike actions across its segments.
While EMN faces headwinds from weak demand and inventory de-stocking in certain markets, it benefits from cost management, pricing actions and innovation.
Better-than-expected earnings performance in the second quarter and upbeat prospects have contributed to the run-up in Eastman's (EMN) shares.
Eastman Chemical (EMN) benefits from cost-management actions, acquisitions and innovation amid challenges from weak demand in certain markets.
The sales volume of Eastman Chemical (EMN) in Q2 increases due to the end of customer inventory destocking in most end markets.
The headline numbers for Eastman Chemical (EMN) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Eastman Chemical (EMN) came out with quarterly earnings of $2.15 per share, beating the Zacks Consensus Estimate of $1.99 per share. This compares to earnings of $1.99 per share a year ago.
Eastman (EMN) is expected to have benefited from cost-cutting and productivity initiatives as well as its innovation-driven growth strategy amid headwinds from soft demand in certain markets in Q2.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Eastman Chemical (EMN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.